Peyman G A, Huamonte F U, Goldberg M F, Sanders D R, Nagpal K C, Raichand M
Arch Ophthalmol. 1978 Jan;96(1):45-50. doi: 10.1001/archopht.1978.03910050009002.
We performed 400 consecutive pars plana vitrectomies, using the vitrophage. Most patients (68%) showed some degree of visual improvement; only 8% had a decline in visual acuity postoperatively. The major operative complications were controllable bleeding from iris vessels and intravitreal stalks (19%) and retinal tears (2%). No retinal dialysis was noted. The major, early postoperative complications were related to corneal decompensation in 38% of the cases; this persisted beyond two weeks in only 7%. Increased intraocular pressure occurred in 19% and postoperative rubeosis iridis developed in 10% of the diabetic patients. Complications related to rebleeding occurred in 18% of the diabetic patients within the first two weeks, and an additional 9% had late rebleeding. Less frequent complications included one case of endophthalmitis, late retinal detachment in 5%, and phthisis bulbi in 2% of all cases. All complications were considerably more frequent and severe in the diabetic population.
我们使用玻璃体吞噬细胞连续进行了400例经睫状体平坦部玻璃体切除术。大多数患者（68%）视力有一定程度的改善；只有8%的患者术后视力下降。主要手术并发症为虹膜血管和玻璃体内蒂部可控性出血（19%）以及视网膜裂孔（2%）。未发现视网膜脱离。主要的早期术后并发症与38%的病例角膜失代偿有关；其中仅7%持续超过两周。19%的患者发生眼压升高，10%的糖尿病患者术后发生虹膜新生血管。18%的糖尿病患者在术后两周内发生与再出血相关的并发症，另有9%发生晚期再出血。较少见的并发症包括1例眼内炎、5%的患者发生晚期视网膜脱离以及2%的病例发生眼球痨。所有并发症在糖尿病患者中都更为常见和严重。
